Hartman et al v. Janssen Research & Development LLC et al
| Hartman, Steven W Hartman and Nancy Linguti |
| Janssen Research & Development LLC, Janssen Pharmaceuticals, Inc., Bayer Healthcare LLC, Janssen Ortho LLC, Bayer AG, Bayer Healthcare AG, Bayer Healthcare Pharmaceuticals, Inc., Bayer Corporation, Bayer Pharma AG, Janssen Pharmaceutica Inc., Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Johnson and Johnson Pharmaceutical Research and Development LLC |
| 2:2015cv00455 |
| January 29, 2015 |
| US District Court for the Eastern District of New York |
| Central Islip Office |
| Sandra J Feuerstein |
| Arlene R Lindsay |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 Diversity-Product Liability |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 11, 2015. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Case transferred from New York Eastern has been opened in the Eastern District of Louisiana as case 2:15-cv-00530, filed 03/11/2015. (Mahon, Cinthia) |
| Filing 11 Certified Copy of JPMDL Conditional Transfer Order (CTO-14) received from the USDC, EDLA on MDL No. 2592 IN RE: XARELTO (RIVAROXABAN) PRODUCTS LIABILITY LITIGATION. This action is transferred under 28 U.S.C. 1407 to the Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the consent of that court, assigned to the Honorable Eldon E. Fallon. Ordered by Jeffery N. Luthi, Clerk of the Panel on 2/18/15. c/m by cm/ecf. (Mahon, Cinthia) |
| Filing 10 SUMMONS Returned Executed by Nancy Linguti, Steven W Hartman. Bayer Corporation served on 2/3/2015, answer due 2/24/2015. (Relkin, Ellen) |
| Case extracted and electronically transferred to the Eastern District of Louisiana. ALL FILINGS ARE TO BE MADE IN THE TRANSFER COURT, DO NOT DOCKET TO THIS CASE. MDL No. 2592 IN RE: XARELTO (RIVAROXABAN) PRODUCTS LIABILITY LITIGATION (Mahon, Cinthia) |
| Filing 9 NEFs received from the JPMDL regarding the filing of a Conditional Transfer Order (CTO-14) and Minute Order to Involved Clerks re: MDL No. 2592 IN RE: Xarelto (Rivaroxaban) Products Liability Litigation. Directing the Order to the Clerk of the USDC for the EDLA for filing. The Panel governing statute, 28 U.S.C. 1407, requires that the transferee clerk transmit a certified copy of the Panel order to transfer to the clerk of the district court from which the action is being transferred. Signed by Clerk of the Panel Jeffery N. Luthi on 2/18/15. (Attachments: #(1) NEF of Minute Order) (Mahon, Cinthia) |
| Filing 8 SUMMONS Returned Executed by Nancy Linguti, Steven W Hartman. Bayer Healthcare Pharmaceuticals, Inc. served on 2/2/2015, answer due 2/23/2015. (Relkin, Ellen) |
| Filing 7 SUMMONS Returned Executed by Nancy Linguti, Steven W Hartman. Bayer Healthcare LLC served on 2/2/2015, answer due 2/23/2015. (Relkin, Ellen) |
| Filing 6 SUMMONS Returned Executed by Nancy Linguti, Steven W Hartman. Janssen Research & Development LLC f/k/a Johnson and Johnson Pharmaceutical Research and Development LLC served on 2/2/2015, answer due 2/23/2015. (Relkin, Ellen) |
| Filing 5 SUMMONS Returned Executed by Nancy Linguti, Steven W Hartman. Janssen Pharmaceuticals, Inc. f/k/a Janssen Pharmaceutica Inc. f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc. served on 1/30/2015, answer due 2/20/2015. (Relkin, Ellen) |
| NOTICE of Hearing: Initial Conference set for 6/30/2015 11:15 AM in Courtroom 1010 before Judge Sandra J. Feuerstein at the Central Islip Courthouse, located at 100 Federal Plaza, Central Islip, New York 11722. The parties shall appear with authority, or with individuals with authority, to settle this matter. Plaintiffs shall serve a copy of this Notice of Hearing upon defendants and file proof of such service with the Court. c/ECF (Adell, April) |
| Filing 4 Summons Issued as to Bayer AG, Bayer Corporation, Bayer Healthcare AG, Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc., Bayer Pharma AG, Janssen Ortho LLC, Janssen Pharmaceuticals, Inc. f/k/a Janssen Pharmaceutica Inc. f/k/a Ortho-McNeil-Janssen Pharmaceuticals, Inc., Janssen Research & Development LLC f/k/a Johnson and Johnson Pharmaceutical Research and Development LLC. (Florio, Lisa) |
| Filing 3 In accordance with Rule 73 of the Federal Rules of Civil Procedure and Local Rule 73.1, the parties are notified that if all parties consent a United States magistrate judge of this court is available to conduct all proceedings in this civil action including a (jury or nonjury) trial and to order the entry of a final judgment. Attached to the Notice is a blank copy of the consent form that should be filled out, signed and filed electronically only if all parties wish to consent. The form may also be accessed at the following link:http://www.uscourts.gov/uscourts/FormsAndFees/Forms/AO085.pdf. You may withhold your consent without adverse substantive consequences. Do NOT return or file the consent unless all parties have signed the consent. (Danisi, Cristine) |
| Filing 2 This attorney case opening filing has been checked for quality control. See the attachment for corrections that were made, if any. (Danisi, Cristine) |
| Judge Sandra J. Feuerstein and Magistrate Judge Arlene R. Lindsay added. (Danisi, Cristine) |
| Filing 1 COMPLAINT against All Defendants filing fee $ 400, receipt number 0207-7489187 Was the Disclosure Statement on Civil Cover Sheet completed -No,, filed by Nancy Linguti, Steven W Hartman. (Attachments: #1 Civil Cover Sheet, #2 Summons) (Relkin, Ellen) Modified on 2/3/2015 (Danisi, Cristine). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New York Eastern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
